<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35291364</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1937-8688</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>The Pan African medical journal</Title><ISOAbbreviation>Pan Afr Med J</ISOAbbreviation></Journal><ArticleTitle>Two-month follow-up of persons with SARS-CoV-2 infection-Zambia, September 2020: a cohort study.</ArticleTitle><Pagination><StartPage>26</StartPage><MedlinePgn>26</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">26</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.11604/pamj.2022.41.26.30721</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">COVID-19 is often characterized by an acute upper respiratory tract infection. However, information on longer-term clinical sequelae following acute COVID-19 is emerging. We followed a group of persons with COVID-19 in Zambia at two months to assess persistent symptoms.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">in September 2020, we re-contacted participants from SARS-CoV-2 prevalence studies conducted in Zambia in July 2020 whose polymerase chain reaction (PCR) tests were positive. Participants with valid contact information were interviewed using a structured questionnaire that captured demographics, pre-existing conditions, and types and duration of symptoms. We describe the frequency and duration of reported symptoms and used chi-square tests to explore variability of symptoms by age group, gender, and underlying conditions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">of 302 participants, 155 (51%) reported one or more acute COVID-19-related symptoms in July 2020. Cough (50%), rhinorrhoea (36%) and headache (34%) were the most frequently reported symptoms proximal to diagnosis. The median symptom duration was 7 days (IQR: 3-9 days). At a median follow up of 54 days (IQR: 46-59 day), 27 (17%) symptomatic participants had not yet returned to their pre-COVID-19 health status. These participants most commonly reported cough (37%), headache (26%) and chest pain (22%). Age, sex, and pre-existing health conditions were not associated with persistent symptoms.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">a notable percentage of persons with SARS-CoV-2 infection in July still had symptoms nearly two months after their diagnosis. Zambia is implementing &#xb4;post-acute COVID-19 clinics&#xb4; to care for patients with prolonged symptoms of COVID-19, to address their needs and better understand how the disease will impact the population over time.</AbstractText><CopyrightInformation>Copyright: James Exnobert Zulu et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zulu</LastName><ForeName>James Exnobert</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Zambia Field Epidemiology Training Program, Zambia National Public Health Institute, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Workforce Development Cluster, Zambia National Public Health Institute, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health, Eastern Province Health Office, Chipata, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Dabwitso</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Zambia Field Epidemiology Training Program, Zambia National Public Health Institute, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Workforce Development Cluster, Zambia National Public Health Institute, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tropical Diseases Research Centre, Ndola, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hines</LastName><ForeName>Jonas Zajac</ForeName><Initials>JZ</Initials><AffiliationInfo><Affiliation>Divison of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luchembe</LastName><ForeName>Musisye</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, University Teaching Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, Ministry of Health, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivile</LastName><ForeName>Suilanje</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, University Teaching Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, Ministry of Health, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siwingwa</LastName><ForeName>Mpanji</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, University Teaching Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, Ministry of Health, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kampamba</LastName><ForeName>Davies</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, University Teaching Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, Ministry of Health, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zyambo</LastName><ForeName>Khozya Davie</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, University Teaching Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, Ministry of Health, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chirwa</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, University Teaching Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, Ministry of Health, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chirwa</LastName><ForeName>Lameck</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, University Teaching Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, Ministry of Health, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malambo</LastName><ForeName>Warren</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Divison of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barradas</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Divison of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinyange</LastName><ForeName>Nyambe</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Zambia Field Epidemiology Training Program, Zambia National Public Health Institute, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Workforce Development Cluster, Zambia National Public Health Institute, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agolory</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Divison of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulenga</LastName><ForeName>Lloyd Berdad</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, University Teaching Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, Ministry of Health, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fwoloshi</LastName><ForeName>Sombo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, University Teaching Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease and Control, Ministry of Health, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Uganda</Country><MedlineTA>Pan Afr Med J</MedlineTA><NlmUniqueID>101517926</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015024" MajorTopicYN="N" Type="Geographic">Zambia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Zambia</Keyword><Keyword MajorTopicYN="N">cough</Keyword><Keyword MajorTopicYN="N">follow-up study</Keyword><Keyword MajorTopicYN="N">headache</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>16</Day><Hour>5</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35291364</ArticleId><ArticleId IdType="pmc">PMC8895565</ArticleId><ArticleId IdType="doi">10.11604/pamj.2022.41.26.30721</ArticleId><ArticleId IdType="pii">PAMJ-41-26</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Medrxiv . University of Basel. 2020. COVID-19 Scenarios: an interactive tool to explore the spread and associated morbidity and mortality of SARS-CoV-2. Accessed August 8, 2020.</Citation></Reference><Reference><Citation>Pearson CA, Van Schalkwyk C, Foss AM, O'Reilly KM. SACEMA Modelling and Analysis Response Team; CMMID COVID-19 working group, Pulliam JR. Projected early spread of COVID-19 in Africa through 1 June 2020. Euro Surveill. 2020 May;25(18):2000543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7219031</ArticleId><ArticleId IdType="pubmed">32400361</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulenga LB, Hines JZ, Fwoloshi S, Chirwa L, Siwingwa M, Yingst S, et al. Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey. Lancet Glob Health. 2021 Jun;9(6):e773&#x2013;e781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8382844</ArticleId><ArticleId IdType="pubmed">33711262</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, et al. Long-term consequences of COVID-19: research needs. Lancet Infect Dis. 2020 Oct;20(10):1115&#x2013;1117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanes-Lane M, Winters N, Fregonese F, Bastos M, Perlman-Arrow S, Campbell JR, et al. Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: a systematic review and meta-analysis. PLoS One. 2020;15(11):e0241536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7608887</ArticleId><ArticleId IdType="pubmed">33141862</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M, Kuppalli K, Kindrachuk J, Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020;371:m3862.</Citation><ArticleIdList><ArticleId IdType="pubmed">33097561</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE) National Institute for Health and Care Excellence (NICE) 2020. COVID-19 rapid guideline: managing the long-term effects of COVID-19.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention Post-COVID conditions. 2021.</Citation></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021 Feb;27(2):258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network-United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group Persistent symptoms in patients after acute COVID-19. JAMA. 2020 Aug 11;324(6):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res. 2020;21(1):163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323373</ArticleId><ArticleId IdType="pubmed">32600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Ye L, Xia R, Zheng X, Yuan C, Wang Z, et al. Chest computed tomography and clinical follow-up of discharged patients with COVID-19 in Wenzhou City, Zhejiang, China. Ann Am Thorac Soc. 2020 Oct;17(10):1231&#x2013;1237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7640627</ArticleId><ArticleId IdType="pubmed">32692945</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27(1):89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome. ERJ Open Res. 2020 Oct 26;6(4):00542&#x2013;2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AW, Shah AS, Johnston JC, Carlsten C, Ryerson CJ. Patient-reported outcome measures after COVID-19: a prospective cohort study. Eur Respir J. 2020 Nov 26;56(5):2003276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7530908</ArticleId><ArticleId IdType="pubmed">33008936</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Alcoba G, Aebischer Perone S, Courvoisier D, Chappuis F, et al. COVID-19 symptoms: longitudinal evolution and persistence in outpatient settings. Ann Intern Med. 2021 May;174(5):723&#x2013;725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Shang Y, Song W, Li Q, Xie H, Xu Q, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Hines JZ, Fwoloshi S, Kampamba D, Barradas DT, Banda D, Zulu JE, et al. SARS-CoV-2 prevalence among outpatients during community transmission, Zambia, July 2020. Emerg Infect Dis. 2021 Aug;27(8):2166&#x2013;2168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8314838</ArticleId><ArticleId IdType="pubmed">34287124</ArticleId></ArticleIdList></Reference><Reference><Citation>Fwoloshi S, Hines JZ, Barradas DT, Yingst S, Siwingwa M, Chirwa L, et al. Prevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers-Zambia, July 2020. Clin Infect Dis. 2021 Sep 15;73(6):e1321&#x2013;e1328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083617</ArticleId><ArticleId IdType="pubmed">33784382</ArticleId></ArticleIdList></Reference><Reference><Citation>Central Statistical Office (Zambia) 2010 census of population and housing; population and demograhic projections 2011-2035. 2013;142</Citation></Reference><Reference><Citation>StataCorp . College Station. Vol. 14. TX: StataCorp LP; 2015. Stata statistical software: release 14.</Citation></Reference><Reference><Citation>World Health Organization Director-General&#xb4;s opening remarks at the media briefing on COVID-19-24 February 2020. 2020.</Citation></Reference><Reference><Citation>Furukawa NW, Brooks JT, Sobel J. Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic. Emerg Infect Dis. 2020 Jul;26(7):e201595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323549</ArticleId><ArticleId IdType="pubmed">32364890</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Global COVID-19 clinical platform case report form (CRF) for post COVID condition (post COVID-19 CRF) 2021.</Citation></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C, Sinatti D, Ricchiuto A, Carfi A, et al. Preliminary evidence on long COVID in children. medRxiv. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021 Apr;27(4):626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Billig Rose E, Lindsell CJ, Shapiro NI, Files DC, Gibbs KW, et al. Characteristics of adult outpatients and inpatients with COVID-19-11 Academic Medical Centers, United States, March-May 2020. MMWR Morb Mortal Wkly Rep. 2020;69(26):841&#x2013;846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332092</ArticleId><ArticleId IdType="pubmed">32614810</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>You J, Zhang L, Ni-Jia-Ti MY, Zhang J, Hu F, Chen L, et al. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge. J Infect. 2020 Aug;81(2):e150&#x2013;e152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273134</ArticleId><ArticleId IdType="pubmed">32512021</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye ZW, Jin DY. Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future. Sheng Wu Gong Cheng Xue Bao. 2020 Apr 25;36(4):571&#x2013;592.</Citation><ArticleIdList><ArticleId IdType="pubmed">32347053</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. COVID-19: four in 10 people with evidence of past infection had no classic symptoms, study finds. BMJ. 2021;372:n321.</Citation><ArticleIdList><ArticleId IdType="pubmed">33536185</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>